Appointment booking for Dr. Gary Schleiter, MD is currently not available.Dr. Gary Schleiter, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Gary Schleiter, MD (he/him) is a Infectious Disease Doctor in Danbury, CT with over 18 years of experience. What is your opinion of Dr. Gary Schleiter, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Gary Schleiter, MD has received over $1,671 which includes payments from the following companies:
$265.00 from GlaxoSmithKline, LLC.
$184.98 from Janssen Products, LP
$183.60 from ViiV Healthcare Company
$161.30 from EMD Serono, Inc.
$100.53 from Volcano Corporation
$81.44 from KCI USA, Inc
$67.82 from E.R. Squibb & Sons, L.L.C.
$57.40 from AbbVie, Inc.
$55.17 from Organogenesis Inc.
$53.09 from Smith & Nephew, Inc.
$43.30 from AstraZeneca Pharmaceuticals LP
$38.39 from Janssen Biotech, Inc.
$31.13 from Pfizer Inc.
$30.64 from Gilead Sciences Inc
$29.87 from CSL Behring
$27.83 from Actavis Pharma Inc
$27.24 from Merck Sharp & Dohme Corporation
$27.00 from FOREST PHARMACEUTICALS, INC.
$23.77 from Janssen Pharmaceuticals, Inc
$23.33 from Durata Therapeutics Inc.
Payments received by Dr. Gary Schleiter, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!